Sterling doctor David E. Berman treated patients for facial wrinkles with an unapproved drug that was intended for "research purposes only" and "not for human use," according to federal court documents.
Berman, 50, of Reston, pleaded guilty June 12, 2007, to misbranding a drug by offering it for sale in the name of another medication.
Berman was sentenced last week, Tuesday, Oct. 30, in federal court in Alexandria to one year of probation, with special conditions that Berman serve five days in jail and six months of home confinement, according to a press release from U.S. Attorney Chuck Rosenberg. United States Magistrate Judge Thomas Rawles Jones Jr. also ordered Berman to pay a $10,000 fine and restitution of $8,810.
Berman treated patients in 2004 with the unapproved Botulinum Toxin Type A as if it was Botox Cosmetic, a form of the medication that is approved by the Food and Drug Administration for treatment of facial wrinkles, according to the release. He did not inform his patients he was using an unapproved drug, according to court documents.